Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Tetrahexylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 3/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.62 |
| ▸ | TP53 | P04637 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.62 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.62 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.60 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.56 |
| ▸ | LSS | P48449 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL4372098 | 1.00 | SLC22A1 (0.65) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Sulfuric Acid SCHEMBL1697122 | 1.00 | SLC22A1 (0.65) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Tetrahexylammonium SCHEMBL3641187 | 0.98 | SLC22A1 (0.62) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Sulfuric Acid SCHEMBL9792101 | 0.98 | SLC22A1 (0.62) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Sulfuric Acid SCHEMBL11344200 | 0.97 | SLC22A1 (0.68) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Tetrahexylammonium SCHEMBL4146123 | 0.97 | SLC22A1 (0.68) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Tetrapentylammonium SCHEMBL6261128 | 0.97 | SLC22A1 (0.63) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Sulfuric Acid SCHEMBL2320651 | 0.97 | SLC22A1 (0.68) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Sulfuric Acid SCHEMBL6262541 | 0.95 | SLC22A1 (0.59) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| Sulfuric Acid SCHEMBL6260170 | 0.95 | SLC22A1 (0.59) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119510645-A | Method for detecting content of zoledronic acid concentrated solution for injection | 海南葫芦娃药业集团股份有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-119310209-A | Analysis method of related substances of zoledronic acid concentrated solution for injection | 海南葫芦娃药业集团股份有限公司 | 2025-01-14 | — | — | CN | claimed |
| CN-110161168-B | High performance liquid chromatography detection method for zoledronic acid and impurities thereof | 四川科伦药物研究院有限公司 | 2022-12-20 | — | — | CN | claimed |
| CN-115010836-A | Electrochromatic polymer, nano particles and device | 吉林大学 | 2022-09-06 | — | — | CN | claimed |
| CN-108795407-B | Electrochromic material based on action of electrochromic acid and preparation of electrochromic device | 常州铱视光电科技有限公司 | 2021-04-16 | — | — | CN | claimed |
| CN-108949141-B | Preparation method of bistable electrochromic material and application of bistable electrochromic material in preparation of electrochromic device | 常州铱视光电科技有限公司 | 2021-02-05 | — | — | CN | claimed |
| CN-111474268-A | High performance liquid chromatography detection method for foscarnet sodium and impurities thereof | 武汉药品医疗器械检验所 | 2020-07-31 | — | — | CN | claimed |
| CN-106353425-B | Method for detecting related substances in zoledronic acid injection by high performance liquid chromatography | 扬子江药业集团四川海蓉药业有限公司 | 2020-06-02 | — | — | CN | claimed |
| EP-3267963-B1 | POLYMERIZABLE DENTAL MATERIAL HAVING A PHASE TRANSFER CATALYST | KETTENBACH GMBH & CO KG (DE) | 2020-02-12 | — | — | EP | claimed |
| US-10307343-B2 | Polymerizable dental material with a phase transfer catalyst | KETTENBACH GMBH & CO. KG (DE) | 2019-06-04 | — | — | US | claimed |
| US-20160262987-A1 | Polymerizable Dental Material With a Phase Transfer Catalyst | KETTENBACH GMBH & CO. KG (DE) | 2016-09-15 | — | — | US | claimed |
| US-7541312-B2 | Porous carbons from carbohydrates | TDA RESEARCH, INC. (US) | 2009-06-02 | — | — | US | claimed |
| US-7153635-B1 | Thermally developable materials processable at lower temperatures | EASTMAN KODAK COMPANY (US) | 2006-12-26 | — | — | US | claimed |
| US-20050207962-A1 | Porous carbons from carbohydrates | TDA RESEARCH, INC. (US) | 2005-09-22 | — | — | US | claimed |
| US-4849531-A | Process for the preparation of 2,3-epoxyamides | BAYER AKTIENGESELLSCHAFT (DE) | 1989-07-18 | — | — | US | claimed |
| US-12606513-B2 | Formate production method, formic acid production method, and antifreezing agent production method | NITTO DENKO CORPORATION (JP) | 2026-04-21 | — | — | US | disclosed |
| EP-4713313-A2 | TETRAHYDRONAPTHYRIDINE AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD | Springworks Therapeutics, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| US-4849531-A | Process for the preparation of 2,3-epoxyamides | BAYER AKTIENGESELLSCHAFT (DE) | 1989-07-18 | — | — | US | disclosed |
| EP-0300922-A1 | Process for the manufacture of derivatives of benzoic acid | GADOT PETROCHEMICAL INDUSTRIES LTD. (IL) | 1989-01-25 | — | — | EP | disclosed |
| US-4691058-A | Process for producing 1-hydroxy ketones | CIBA-GEIGY CORPORATION (US) | 1987-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10307343-B2 | Polymerizable dental material with a phase transfer catalyst | PRDX4, SMOX, PRDX2 | SLC22A1 924/4885ALDH1A1 1564/4885TP53 3325/4885 |
| US-12606513-B2 | Formate production method, formic acid production method, and antifreezing agent production method | CA2, TAF5, HACL2 | SLC22A1 2007/4885ALDH1A1 1262/4885TP53 3818/4885 |
| US-20160262987-A1 | Polymerizable Dental Material With a Phase Transfer Catalyst | PRDX4, SMOX, PRDX2 | SLC22A1 924/4885ALDH1A1 1564/4885TP53 3325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.